EpiCypher
Chapel Hill
About EpiCypher
EpiCypher develops and manufactures novel products and tools for epigenetics and chromatin biology research. Our team and founders include renowned chromatin researchers, whose expertise and unique insight into epigenetics and chromatin biology benefit our customers in ways that other companies cannot duplicate.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $3.4M
- Last round: Series Unknown (Jul 2024)
- Website: epicypher.com
- Phone: (855) 374-2461
Industries & Categories
3D Printing, Biotechnology, Consumer Goods, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/epicypher-54141 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.